Aurora Cannabis (TSE:ACB – Get Free Report) had its target price dropped by equities researchers at ATB Capital from C$12.50 to C$11.00 in a report released on Friday, BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. ATB Capital’s target price indicates a potential upside of 56.47% from the stock’s current price.
Separately, Jefferies Financial Group decreased their target price on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a report on Tuesday, February 27th.
Check Out Our Latest Research Report on Aurora Cannabis
Aurora Cannabis Stock Down 6.8 %
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
See Also
- Five stocks we like better than Aurora Cannabis
- Why Are Stock Sectors Important to Successful Investing?
- McDonald’s Stock: Balancing Value and Innovation
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- MarketBeat Week in Review – 6/17 – 6/21
- Using the MarketBeat Stock Split Calculator
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.